Longboard Pharmaceuticals Price on September 29, 2023
LBPHDelisted Stock | USD 59.98 0.00 0.00% |
If you're considering investing in Longboard Stock, it is important to understand the factors that can impact its price. As of today, the current price of Longboard Pharmaceuticals stands at 59.98, as last reported on the 22nd of December, with the highest price reaching 59.98 and the lowest price hitting 59.98 during the day. Longboard Pharmaceuticals is not too volatile given 3 months investment horizon. Longboard Pharmaceuticals has Sharpe Ratio of 0.18, which conveys that the firm had a 0.18% return per unit of risk over the last 3 months. We were able to interpolate data for twenty-five different technical indicators, which can help you to evaluate if expected returns of 1.39% are justified by taking the suggested risk. Use Longboard Pharmaceuticals Mean Deviation of 3.24, downside deviation of 4.01, and Risk Adjusted Performance of 0.1149 to evaluate company specific risk that cannot be diversified away.
Longboard Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Longboard |
Sharpe Ratio = 0.181
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | LBPH | |||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
7.66 actual daily | 68 68% of assets are less volatile |
Expected Return
1.39 actual daily | 27 73% of assets have higher returns |
Risk-Adjusted Return
0.18 actual daily | 14 86% of assets perform better |
Based on monthly moving average Longboard Pharmaceuticals is performing at about 14% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Longboard Pharmaceuticals by adding it to a well-diversified portfolio.
Related Headline
Design Therapeutics Headline on 29th of September 2023
Filed transaction by Design Therapeutics Inc director. General open market or private sale of non-derivative or derivative security
Longboard Pharmaceuticals Valuation on September 29, 2023
It is possible to determine the worth of Longboard Pharmaceuticals on a given historical date. On September 29, 2023 Longboard was worth 5.86 at the beginning of the trading date compared to the closed value of 5.56. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Longboard Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Longboard Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Longboard Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Longboard Pharmaceuticals' related companies.
Open | High | Low | Close | Volume | |
5.53 | 5.67 | 5.38 | 5.49 | 23,000 | |
09/29/2023 | 5.86 | 6.12 | 5.54 | 5.56 | 39,200 |
5.54 | 5.87 | 4.75 | 4.90 | 58,300 |
Backtest Longboard Pharmaceuticals | | | Longboard Pharmaceuticals History | | | Longboard Pharmaceuticals Valuation | Previous | Next |
Longboard Pharmaceuticals Trading Date Momentum on September 29, 2023
On October 02 2023 Longboard Pharmaceuticals was traded for 4.90 at the closing time. The top price for the day was 5.87 and the lowest listed price was 4.75 . The trading volume for the day was 58.3 K. The trading history from October 2, 2023 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 11.87% . The trading delta at closing time against the current closing price is 4.68% . |
Longboard Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Longboard Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Longboard Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Longboard financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Longboard Pharmaceuticals Stock history
Longboard Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Longboard is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Longboard Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Longboard Pharmaceuticals stock prices may prove useful in developing a viable investing in Longboard Pharmaceuticals
Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing transformative medicines for neurological diseases. Longboard Pharmaceuticals, Inc. was incorporated in 2020 and is based in La Jolla, California. Longboard Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 21 people.
Longboard Pharmaceuticals Stock Technical Analysis
Longboard Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
Price Boundaries
Longboard Pharmaceuticals Period Price Range
Low | December 22, 2024
| High |
0.00 | 0.00 |
Longboard Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Longboard Pharmaceuticals December 22, 2024 Market Strength
Market strength indicators help investors to evaluate how Longboard Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Longboard Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Longboard Pharmaceuticals stock market strength indicators, traders can identify Longboard Pharmaceuticals entry and exit signals to maximize returns
Longboard Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Longboard Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Longboard Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Longboard to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.1149 | |||
Jensen Alpha | 1.02 | |||
Total Risk Alpha | 0.7775 | |||
Sortino Ratio | 0.2401 | |||
Treynor Ratio | (0.75) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Consideration for investing in Longboard Stock
If you are still planning to invest in Longboard Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Longboard Pharmaceuticals' history and understand the potential risks before investing.
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |